Pay in 4 interest-free payments of $5.90 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Why this can fit your routine
Chen Y, Jacamo R, Konopleva M, Garzon R, Croce CM, Andreeff M
confirmed that overexpressed SLC1A3 in gastric cancer activates the PI3K/AKT pathway, upregulates the expression levels of Glucose transporter 1 (GLUT1), Hexokinase 2 (HK2), and Lactate dehydrogenase A (LDHA), and promotes the growth of gastric cancer, while treatment with the PI3K/AKT inhibitor LY294002 could inhibit the growth-promoting effect of SLC1A3 overexpression on gastric cancer
Crohns Colitis 9 , 10431052 (2015)
US$ 22.35
US$ 24.63
US$ 29.77
US$ 23.28
US$ 26.76
US$ 29.17
US$ 28.01
US$ 20.62
US$ 22.62
US$ 20.82
